[1]
Uchida, M. et al. 2021. Pharmacovigilance Evaluation of Bendamustine-related Skin Disorders using the Japanese Adverse Drug Event Report Database. Journal of Pharmacy & Pharmaceutical Sciences. 24, (Jan. 2021), 16–22. DOI:https://doi.org/10.18433/jpps31597.